Cenovus hikes bid for MEG Energy to C$28.44 per share-March 2024-www.financetom.com

Cenovus hikes bid for MEG Energy to C$28.44 per share

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Cenovus hikes bid for MEG Energy to C$28.44 per share

Sep 20, 2025 10:09 PM

Sept 18 (Reuters) - Cenovus Energy ( CVE ) said on

Thursday it has raised its takeover offer for MEG Energy ( MEGEF )

to C$28.44 per share from C$27.25, intensifying a

months-long bidding war for the Canadian oil sands producer.

Previous page： EXPLAINER-How India's Byju's went from startup star to facing insolvency Next page： Spotify Says App Now Includes Pricing Information for EU iPhone Users

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

EXPLAINER-How India's Byju's went from startup star to facing insolvency

Aug 14, 2024

(Updates with latest developments) By Ashwin Manikandan and VarunVyas Hebbalalu BENGALURU/MUMBAI, Aug. 14 (Reuters) - India's top court revived insolvency proceedings against edtech company Byju's on Wednesday following a lawsuit from U.S. lenders. The latest court order deepens a crisis that has seen the one-time market darling's valuation plunge from about $22 billion to less than $2 billion. Here is...

Spotify Says App Now Includes Pricing Information for EU iPhone Users

Aug 14, 2024

08:05 AM EDT, 08/14/2024 (MT Newswires) -- Spotify Technology ( SPOT ) said Apple ( AAPL ) iPhone users in the European Union may view Spotify's ( SPOT ) pricing information in the app, starting Wednesday. The audio streaming firm said it is opting into Apple's ( AAPL ) music streaming services entitlement following the European Commission's ruling that fined...

Verrica Pharmaceuticals' Shares Surge 26% Pre-Bell on Data From Study of VP-315 to Treat Basal Cell Carcinoma

Aug 14, 2024

08:04 AM EDT, 08/14/2024 (MT Newswires) -- Verrica Pharmaceuticals ( VRCA ) shares surged 26% in recent premarket activity Wednesday after it reported preliminary positive results from the second part of a phase 2 trial of VP-315 to treat basal cell carcinoma. The dermatology therapeutics company said that among the encouraging results, VP-315 was well tolerated with no reported treatment-related...

Sphere Entertainment Swings to Fiscal Q4 Loss, Revenue Rises

Aug 14, 2024

08:07 AM EDT, 08/14/2024 (MT Newswires) -- Sphere Entertainment ( SPHR ) reported a fiscal Q4 loss Wednesday of $1.31 per diluted share, swinging from earnings of $15.24 a year earlier. Analysts polled by Capital IQ expected a loss of $2.04 per share. Revenue for the quarter ended June 30 was $273.4 million, up from $129.1 million a year earlier....